Cite
HARVARD Citation
Mösges, R. et al. (2018). Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients. Allergy. 73 (6), pp. 1254-1262. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mösges, R. et al. (2018). Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B‐cell response in seasonal allergic rhinitis patients. Allergy. 73 (6), pp. 1254-1262. [Online].